Comparative assessment of bioanalytical method validation guidelines for pharmaceutical industry.

The concepts, importance, and application of bioanalytical method validation have been discussed for a long time and validation of bioanalytical methods is widely accepted as pivotal before they are taken into routine use. United States Food and Drug Administration (USFDA) guidelines issued in 2001 have been referred for every guideline released ever since; may it be European Medical Agency (EMA) Europe, National Health Surveillance Agency (ANVISA) Brazil, Ministry of Health and Labour Welfare (MHLW) Japan or any other guideline in reference to bioanalytical method validation. After 12 years, USFDA released its new draft guideline for comments in 2013, which covers the latest parameters or topics encountered in bioanalytical method validation and approached towards the harmonization of bioanalytical method validation across the globe. Even though the regulatory agencies have general agreement, significant variations exist in acceptance criteria and methodology. The present review highlights the variations, similarities and comparison between bioanalytical method validation guidelines issued by major regulatory authorities worldwide. Additionally, other evaluation parameters such as matrix effect, incurred sample reanalysis including other stability aspects have been discussed to provide an ease of access for designing a bioanalytical method and its validation complying with the majority of drug authority guidelines.

[1]  K. Gallicano,et al.  Application issues in bioanalytical method validation, sample analysis and data reporting. , 1995, Journal of pharmaceutical and biomedical analysis.

[2]  A. Falcão,et al.  Linear regression for calibration lines revisited: weighting schemes for bioanalytical methods. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[3]  Patrick G. Swann,et al.  Regulatory considerations for development of bioanalytical assays for biotechnology products. , 2011, Bioanalysis.

[4]  H. Y. Aboul-Enein,et al.  Selectivity versus specificity in chromatographic analytical methods , 2000 .

[5]  Sanford Bolton.  Pharmaceutical statistics: Practical and clinical applications , 1984 .

[6]  J. Wieling,et al.  Rational experimental design for bioanalytical methods validation. Illustration using an assay method for total captopril in plasma. , 1996, Journal of chromatography. A.

[7]  D Dadgar,et al.  Issues in evaluation of bioanalytical method selectivity and drug stability. , 1995, Journal of pharmaceutical and biomedical analysis.

[8]  Stuart McDougall,et al.  Statistical methods for assessing long-term analyte stability in biological matrices. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[9]  Marian Kelley,et al.  ISR: background, evolution and implementation, with specific consideration for ligand-binding assays. , 2014, Bioanalysis.

[10]  A. Bergeron,et al.  Confirmation of no impact from different anticoagulant counter ions on bioanalytical method. , 2012, Bioanalysis.

[11]  Jos H. Beijnen,et al.  BIOANALYTICAL LIQUID CHROMATOGRAPHIC METHOD VALIDATION. A REVIEW OF CURRENT PRACTICES AND PROCEDURES , 2000 .

[12]  Magnus Knutsson,et al.  Anticoagulant counter ion impact on bioanalytical LC-MS/MS assays: results from discussions and experiments within the European Bioanalysis Forum. , 2011, Bioanalysis.

[13]  S. Kollipara,et al.  International Guidelines for Bioanalytical Method Validation: A Comparison and Discussion on Current Scenario , 2011 .

[14]  Erin Chambers,et al.  Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analyses. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[15]  B. Matuszewski,et al.  Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. , 2003, Analytical chemistry.

[16]  Sherry Wang,et al.  Does a stable isotopically labeled internal standard always correct analyte response? A matrix effect study on a LC/MS/MS method for the determination of carvedilol enantiomers in human plasma. , 2007, Journal of pharmaceutical and biomedical analysis.

[17]  Timothy Olah,et al.  Mechanistic investigation of ionization suppression in electrospray ionization , 2000, Journal of the American Society for Mass Spectrometry.

[18]  Vinod P. Shah,et al.  Validation of Bioanalytical Methods , 1991, Pharmaceutical Research.

[19]  Jean W. Lee,et al.  Specificity and selectivity evaluations of ligand binding assay of protein therapeutics against concomitant drugs and related endogenous proteins , 2007, The AAPS Journal.

[20]  Eric Woolf,et al.  Best practices during bioanalytical method validation for the characterization of assay reagents and the evaluation of analyte stability in assay standards, quality controls, and study samples , 2007, The AAPS Journal.